Navigation Links
OneTouch(R) Ping(TM) Glucose Management System Approved by Health Canada
Date:7/15/2009

VANCOUVER, July 15 /PRNewswire/ -- Animas Corporation announced today the approval of its OneTouch((R)) Ping(TM) Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients with unique capabilities designed to make life with diabetes easier and more discreet. A combination of the advanced insulin pump technology from Animas and trusted OneTouch blood glucose monitor technology, the OneTouch Ping frees people living with diabetes from multiple daily injections, while offering discretion and convenience through remote insulin dosing," said Henry Anhalt, D.O., Director of Medical Affairs, Animas Corporation. "Animas is pleased to bring this advancement to people with diabetes in Canada."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson: Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch((R)) Ultra((R)) Test Strips.

OneTouch Ping also offers the following:

  • Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 3.6 meters (12 feet) for 24 hours, and has a color screen for outstanding pump readability
  • Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs
  • Proven blood glucose monitoring technology - the meter-remote utilizes the OneTouch((R)) Ultra((R)) test strip, the #1-selling test strip in Canada and #1 test strip preferred among insulin users in Canada.( )OneTouch((R)) Ultra((R)) test strips have more than 6 years of proven accuracy and use patented DoubleSure(TM) technology to automatically check and confirm results for accuracy

ezManager((R)) MAX Diabetes Management Software

The OneTouch Ping system will also work with the ezManager((R)) MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager((R)) MAX software is MAC and PC compatible.

OneTouch Ping will be available for shipment on Friday, July 24. Customers can order at any time by calling 1-866-406-4844 or by visiting www.OneTouchPing.ca.

About Animas Corporation

As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products available in Canada, visit www.Animas.ca.

About LifeScan, Inc.

LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures, and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit www.OneTouch.ca.


'/>"/>
SOURCE Animas Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes
2. OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
3. Photos: OneTouch(R) Features Five Participants From Global Diabetes Handprint Project in National Awareness and Fundraising Campaign
4. *** Diabetes Alert Day *** OneTouch(R) Offers Cost Saving Tips to Help Diabetes Patients Maintain Good Health in Tough Economy
5. Scientists explain how insulin secreting cells maintain their glucose sensitivity
6. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
7. Increased glucose level is a strong risk factor for colorectal cancer
8. Got sugar? Glucose affects our ability to resist temptation
9. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
10. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
11. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology: